SARS-CoV-2 vaccination responses in untreated, conventionally treated and anticytokine-treated patients with immune-mediated inflammatory diseases
Objectives To better understand the factors that influence the humoral immune response to
vaccination against SARS-CoV-2 in patients with immune-mediated inflammatory diseases …
vaccination against SARS-CoV-2 in patients with immune-mediated inflammatory diseases …
Safety and immunogenicity of a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases compared with healthy controls
F Kartnig, D Mrak, E Simader, S Tobudic… - Annals of the …, 2023 - ard.bmj.com
Objectives A third COVID-19 vaccination is recommended for immunosuppressed patients.
However, data on immunogenicity and safety of a third COVID-19 vaccination in patients …
However, data on immunogenicity and safety of a third COVID-19 vaccination in patients …
Perspective of patients with autoimmune diseases on COVID-19 vaccination
L Boekel, F Hooijberg, ZLE van Kempen… - The Lancet …, 2021 - thelancet.com
The socioeconomic burden of COVID-19 and pressure on health-care systems can only be
reduced by achieving herd immunity against SARS-CoV-2. For herd immunity to be …
reduced by achieving herd immunity against SARS-CoV-2. For herd immunity to be …
Factors associated with COVID-19 breakthrough infection among vaccinated patients with rheumatic diseases: a cohort study
Objective Rheumatic disease patients on certain immunomodulators are at increased risk of
impaired humoral response to SARS-CoV-2 vaccines. We aimed to identify factors …
impaired humoral response to SARS-CoV-2 vaccines. We aimed to identify factors …
COVID‐19 vaccination in patients with rheumatic diseases: vaccination rates, patient perspectives, and side effects
YK Li, MPK Lui, LL Yam, CS Cheng… - Immunity …, 2022 - Wiley Online Library
Introduction To investigate the vaccination rate, reported side effects, and patient concerns
for COVID‐19 vaccination in patients with rheumatic diseases. Methods A multicentre cross …
for COVID‐19 vaccination in patients with rheumatic diseases. Methods A multicentre cross …
American College of Rheumatology guidance for COVID‐19 vaccination in patients with rheumatic and musculoskeletal diseases: version 2
JR Curtis, SR Johnson, DD Anthony… - Arthritis & …, 2021 - Wiley Online Library
Objective To provide guidance to rheumatology providers on the use of coronavirus disease
2019 (COVID‐19) vaccines for patients with rheumatic and musculoskeletal diseases …
2019 (COVID‐19) vaccines for patients with rheumatic and musculoskeletal diseases …